A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase 3 Study of Denosumab as Adjuvant Treatment for Women with Early -Stage Breast Cancer at High Risk of Recurrence (D-CARE)

Project: Research

Participants

Colleges, School and Institutes

Short titleA Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase 3 Study of Denosumab as Adjuvant Treatment for Women with Early -Stage Breast Cancer at High Risk of Recurrence (D-CARE)
StatusFinished
Effective start/end date27/09/1024/09/18